MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bulseco, D. A.
Right arrow Articles by Schimerlik, M. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bulseco, D. A.
Right arrow Articles by Schimerlik, M. I.

Single amino acid substitutions in the pm2 muscarinic receptor alter receptor/G protein coupling without changing physiological responses

DA Bulseco and MI Schimerlik

Department of Biochemistry and Biophysics, Oregon State University, Corvallis 97331, USA.

The amino terminus of the third cytoplasmic loop of the porcine m2 muscarinic receptor plays an important role in receptor/effector coupling. Although large changes in coupling properties are easily detected, subtle changes are often overlooked. Three mutant receptors were characterized after expression in Chinese hamster ovary cells, and two of these exhibited subtle changes in coupling properties. Substitution of amino acids 219-223 (KDKKE) with those conserved in the m1/m3/m5 receptor subtype family (ELAAL) had little effect on coupling to effector systems, indicating that altering the charge distribution in this region did not affect receptor/G protein interactions. Substitution of alanine with glutamate at amino acid position 212 (A212E) or lysine with alanine in position 214 (K214A) resulted in receptors with IC50 values for inhibition of adenylyl cyclase that resembled those of wild-type, although maximal percent inhibition was reduced. All mutants moderately decreased coupling to phosphatidylinositol metabolism, but mutant A212E caused oxotremorine-M to become a weak partial agonist compared with carbachol, suggesting that receptor conformation is agonist dependent even for ligands normally thought of as full agonists. K214A coupled to PI metabolism through both PTX-sensitive and PTX-insensitive G proteins. The results indicated that these mutants superficially possessed effector coupling characteristics similar to those of wild-type, but on more detailed examination G protein/receptor interactions were altered.

Volume 49, Issue 1, pp. 132-141, 01/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
X.-P. Huang, F. E. Williams, S. M. Peseckis, and W. S. Messer Jr.
Pharmacological Characterization of Human m1 Muscarinic Acetylcholine Receptors with Double Mutations at the Junction of TM VI and the Third Extracellular Domain
J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1129 - 1139.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1996 by the American Society for Pharmacology and Experimental Therapeutics